Related Experiment Video
Updated: Jan 25, 2026

07:47
Reporter-based Growth Assay for Systematic Analysis of Protein Degradation
Published on: November 6, 2014
11.1K
Inconsistent outcome reporting in large neonatal trials: a systematic review
James William Harrison Webbe1, Shohaib Ali2, Susanna Sakonidou1
1Section of Neonatal Medicine, Imperial College London, London, UK.
Summary
Neonatal clinical trials show inconsistent outcome reporting, with limited parent or former patient involvement. Developing a core outcome set is recommended to improve research quality and clinical relevance.
Area of Science:
- Neonatal research
- Clinical trial methodology
- Evidence-based medicine
Background:
- Inconsistent outcome selection and reporting in clinical trials contribute to research waste.
- The prevalence of this issue in neonatal trials is not well-documented.
- Standardized outcome reporting is crucial for reliable research findings.
Purpose of the Study:
- To assess outcome reporting consistency in large neonatal clinical trials.
- To examine the use of composite outcomes in these trials.
- To determine the extent of parent or former patient involvement in outcome selection.
Main Methods:
- A systematic literature search was performed across major databases (CENTRAL, CINAHL, EMBASE, MEDLINE).
- Randomized trials involving at least 100 infants per arm, published between July 2012 and July 2017, were included.
- Outcomes, outcome measures, and parent/former patient involvement were extracted and categorized.
Main Results:
- Seventy-six trials with 43,126 infants were analyzed, reporting 216 distinct outcomes and 889 measures.
- Outcome reporting was highly variable; only 88% reported survival, and most outcome measures appeared in single trials.
- Thirty-three composite outcomes were used, but no trials reported parent or former patient involvement in outcome selection.
Conclusions:
- Inconsistent outcome reporting and lack of stakeholder involvement in neonatal trials hinder clinically meaningful research.
- Establishing a core outcome set for neonatal trials, with multi-stakeholder input, is essential.
- This initiative aims to enhance the quality and relevance of future neonatal research.
Related Concept Videos
Review and Preview
8.3K
In statistics, several tools are used to interpret the data. Measures of central tendency represent the characteristics of the data, such as mean, median, and mode. Additionally, measures of variance like standard deviation and range are used to find the spread of data from the mean. Relative standing measures the distance between data locations. Commonly used measures of relative standings are percentile, z score, and quartiles.
Percentiles are a type of fractile that partition data into...
Percentiles are a type of fractile that partition data into...
8.3K
Review and Preview
10.9K
Data are individual items of information obtained from a population or sample. Data may be classified as qualitative (categorical), quantitative continuous, or quantitative discrete. Because it is not practical to measure the entire population in a study, researchers use samples to represent the population. A random sample is a representative group from the population chosen by using a method that gives each individual in the population an equal chance of being included in the sample. Random...
10.9K
Clinical Trials
10.2K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.2K
Clinical Trials: Overview
4.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.7K
Trial and Error and Algorithm
403
A problem-solving strategy is a plan of action used to find a solution. Different strategies have distinct action plans. Trial and error involves trying different solutions until one works. For instance, to fix a broken printer, you might check ink levels, ensure the paper tray isn't jammed, and verify the printer's connection to your laptop. This method can be time-consuming but is commonly used. Thomas Edison, for example, used trial and error to find a suitable filament for the light...
403
Random and Systematic Errors
14.7K
Scientists always try their best to record measurements with the utmost accuracy and precision. However, sometimes errors do occur. These errors can be random or systematic. Random errors are observed due to the inconsistency or fluctuation in the measurement process, or variations in the quantity itself that is being measured. Such errors fluctuate from being greater than or less than the true value in repeated measurements. Consider a scientist measuring the length of an earthworm using a...
14.7K

